![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1364958
»ý¸í°úÇÐ ±â±â ½ÃÀå : ±â¼úº°(ºÐ±¤, Çö¹Ì°æ, Å©·Î¸¶Åä±×·¡ÇÇ(HPLC, GC, TLC), PCR, ¸é¿ªÃøÁ¤, ½ÃÄö½Ì, À¯¼¼Æ÷ºÐ¼®, ½ÇÇè½Ç ÀÚµ¿È, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Àü±â¿µµ¿, ÀÎÅ¥º£ÀÌÅÍ, ¿ø½ÉºÐ¸®±â) - ¼¼°è ¿¹Ãø(-2030³â)Life Science Equipment Market by Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User - Global Forecast to 2030 |
»ý¸í°úÇÐ ±â±â ½ÃÀå : ±â¼úº°(ºÐ±¤, Çö¹Ì°æ, Å©·Î¸¶Åä±×·¡ÇÇ(HPLC, GC, TLC), PCR, ¸é¿ªÃøÁ¤, ½ÃÄö½Ì, À¯¼¼Æ÷ºÐ¼®, ½ÇÇè½Ç ÀÚµ¿È, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Àü±â¿µµ¿, ÀÎÅ¥º£ÀÌÅÍ, ¿ø½ÉºÐ¸®±â) ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(-2030³â)
»ý¸í°úÇÐ ±â±â ½ÃÀåÀº 2023-2030³âÀÇ CAGRÀÌ 6.2%·Î, 2030³â¿¡´Â 922¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ º¸°í¼´Â ±¤¹üÀ§ÇÑ 1Â÷ ¹× 2Â÷ ¿¬±¸¸¦ ÅëÇØ »ý¸í°úÇÐ ±â±â ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ »ý¸í°úÇÐ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, °úÁ¦ ¹× ±âȸ¿¡ ´ëÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù. »ý¸í°úÇÐ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº Á¦¾à ¹× »ý¸í°øÇÐ R&D ºñ¿ë Áõ°¡, »ý¸í°úÇÐ R&D¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ±¸»ó, ¸¸¼ºÁúȯ ¹× °¨¿°¼º Áúȯ Áõ°¡, ȯ°æ¿À¿°À» ¾ïÁ¦Çϱâ À§ÇÑ ³ë·ÂÀÇ È®´ë°¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï ±¹°¡¿¡¼´Â ÷´Ü ÀåºñÀÇ ³ôÀº ºñ¿ë°ú ÀÚ±Ý ¹× ÀÎÇÁ¶óÀÇ Á¦¾àÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ À¯ÀüüÇÐ ¹× ´Ü¹éÁúüÇÐÀÇ ¼ºÀå, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ Àνİú äÅà Ȯ´ë, »ý¸í°úÇÐ »ê¾÷ÀÇ ÀÚµ¿È ¹× µðÁöÅÐÈ ¹ßÀü, ½Äǰ ¾ÈÀü ¹× ǰÁú¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ÀÌ ½ÃÀå¿¡¼ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷¿¡°Ô ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÷´Ü °Ë»ç Àåºñ ¿î¿µ¿¡ ÇÊ¿äÇÑ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú µ¥ÀÌÅÍ º¸¾È ¹®Á¦´Â ½ÃÀå ÀÌÇØ°ü°èÀڵ鿡°Ô Å« µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¿¡ Æ÷ÇÔµÈ ±â¼ú Áß 2023³âÀÇ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â ½ÃÄö½Ì ºÐ¾ßÀÔ´Ï´Ù. ³ôÀº ¼öÀ²°ú ¿À·ù ¾ø´Â 󸮷®À» »ý¼ºÇÏ´Â ½ÃÄö½Ì ±â¼úÀÇ ´É·Â, ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼ÀÇ ±â¼ú ÅëÇÕ È®´ë, Á¦Ç° Á¦°ø È®´ë ¹× °³¼±À» À§ÇÑ ½ÃÄö½Ì Àåºñ Á¦Á¶¾÷ü °£ÀÇ ÆÄÆ®³Ê½Ê ¹× Çù¾÷ Áõ°¡´Â ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.
ÀÌ º¸°í¼¿¡ Æ÷ÇÔµÈ ÃÖÁ¾»ç¿ëÀÚ Áß Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ ºÎ¹®Àº 2023³â »ý¸í°úÇÐ ±â±â ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº ½ÃÀå Á¡À¯À²Àº °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ ¿¬±¸ Áõ°¡, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷°ú CRO °£ÀÇ Çù·Â °ü°è È®´ë°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
»ý¸í°úÇÐ ±â±â ½ÃÀåÀÇ Áö¿ªº° ½Ã³ª¸®¿À¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®Àº 5°³ ÁÖ¿ä Áö¿ª(ºÏ¹Ì, Áö¿ªº° ½ÃÀå, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¤¼ºÀû ¹× Á¤·®Àû ÀλçÀÌÆ®¿Í °¢ Áö¿ªÀÇ ÁÖ¿ä ±¹°¡¿¡ ´ëÇÑ Ä¿¹ö¸®Áö¸¦ Á¦°øÇÕ´Ï´Ù. °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«°¡ ±× µÚ¸¦ ÀÌÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ÙÀÌ¿À½Ã¹Ð·¯ ¹× Á¦³×¸¯ ÀǾàǰÀÇ ¸¹Àº ½ÂÀÎÀ¸·Î À̾îÁö´Â ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ ³ôÀº À¯º´·ü, ÷´Ü ±â¼úÀÇ ³ôÀº äÅ÷ü, È®¸³µÈ ÀÇ·á ½Ã½ºÅÛ, »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ È°¹ßÇÑ ÀÚ±Ý Áö¿ø Ȱµ¿ µîÀÌ ÀÌ ½ÃÀåÀÇ ÃÖ´ë Á¡À¯À²À» Áö¿øÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
»ý¸í°úÇÐ ±â±â ½ÃÀåÀÇ ±â¼úº° Æò°¡
Âü°í: ±âŸ ºÐÀÚ ºÐ±¤ ±â¼ú ºÐ¾ß¿¡´Â ¶ó¸¸ ºÐ±¤¹ý, Ÿ¿øÇü ºÐ±¤¹ý, »ö ÃøÁ¤ µîÀÌ ÀÖ½À´Ï´Ù.
ÁÖ: ±âŸ ¿øÀÚ ºÐ±¤ ±â¼ú¿¡´Â À¯µµ°áÇÕÇöóÁ(ICP) ºÐ±¤¹ý, ±Û·Î¿ì ¹æÀü ºÐ±¤¹ý, ¾ÆÅ©/½ºÆÄÅ© ¹ß±¤ ºÐ±¤¹ý µîÀÌ ÀÖ½À´Ï´Ù.
Âü°í: ±âŸ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿¡´Â ´ç¼â ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, ź¼öȹ° ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, ÈÇÕ¹° ¸¶ÀÌÅ©·Î¾î·¹À̰¡ Æ÷ÇԵ˴ϴÙ.
Âü°í: ±âŸ Àåºñ ºÎ¹®¿¡´Â ¿ÀÅäŬ·¹À̺ê, ±³¹Ý±â ¹× ¼ÎÀÌÄ¿, ¹Í¼, ¿åÁ¶, ÇÖ Ç÷¹ÀÌÆ®, ¿Àºì ¹× ¿ë±¤·Î, Àú¿ïÀÌ Æ÷ÇԵ˴ϴÙ.
»ý¸í°úÇÐ ±â±â ½ÃÀå Æò°¡-ÃÖÁ¾»ç¿ëÀÚº°
ÁÖ: ±âŸ ÃÖÁ¾»ç¿ëÀÚ¿¡´Â Ç÷¾×ÀºÇà, ÈÀåǰ, ÈÇÐ, ¼®À¯ ¹× °¡½º, ÀüÀÚ ¹× ¹ÝµµÃ¼, ÀÚµ¿Â÷, Ç×°ø¿ìÁÖ, ¼¼¶ó¹Í, ÇÃ¶ó½ºÆ½, °í¹«, ÆäÀÎÆ® ¹× ÄÚÆÃ µîÀÇ »ê¾÷ÀÌ Æ÷ÇԵ˴ϴÙ.
»ý¸í°úÇÐ ±â±â ½ÃÀå Æò°¡-Áö¿ªº°
Life Science Equipment Market By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User- Global Forecast to 2030
The life science equipment market is expected to reach $92.21 billion by 2030, at a CAGR of 6.2% from 2023 to 2030.
After extensive primary and secondary research, the report provides an in-depth analysis of the life science equipment market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the life science equipment market. The growth of the life science equipment market is driven by the increasing pharmaceutical and biotech R&D expenditures, government initiatives supporting life sciences R&D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution. However, the high costs of advanced equipment and funding and infrastructure limitations in developing countries restrain the growth of this market.
Furthermore, the growth in genomics and proteomics, the increasing awareness and growing adoption of personalized medicines, increasing automation and digitalization in the life sciences industry, and the increasing focus on food safety and quality are generating growth opportunities for the players operating in this market. However, the lack of skilled professionals required for operating advanced laboratory equipment and data security concerns are major challenges for market stakeholders.
Among the technologies included in the report, in 2023, the sequencing segment is projected to register the highest CAGR during the forecast period. The capability of sequencing technology to generate high-yield error-free throughput, the growing integration of this technology in clinical and research settings, and increasing partnerships and collaborations among sequencing instrument manufacturers to expand and improve product offerings are some of the factors contributing to the growth of the segment.
Among the end users included in the report, in 2023, the pharmaceutical and biotechnology industry segment is estimated to account for the largest share of the life science equipment market. The large market segment share is majorly attributed to the increased attention towards personalized medicine, growth in the number of research studies covering biologics and biosimilars, and growing collaborations among pharmaceutical & biotechnology companies and CROs.
An in-depth analysis of the geographical scenario of the life science equipment market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the life science equipment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases leading to a large number of approvals of biosimilars and generics, high adoption of advanced technologies, a well-established healthcare system, and increased funding activities for life science research are some of the factors supporting the largest share of this market.
The key players operating in the life science equipment market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and Qiagen N.V. (Netherlands).
Life Science Equipment Market Assessment-by Technology
Note: Other molecular spectroscopy technologies segment includes Raman spectroscopy, ellipsometry, and color measurement.
Note: Other atomic spectroscopy technologies segment includes inductively coupled plasma (ICP) spectroscopy, glow discharge spectroscopy, and arc/spark optical emission spectroscopy.
Note: Other microarrays segment includes glycan microarray, carbohydrate microarray, and chemical compounds microarray.
Note: Other equipment segment includes autoclaves, stirrers & shakers, mixers, baths, hot plates, ovens & furnaces, and balances.
Life Science Equipment Market Assessment -by End User
Note: Other end users include blood banks and industries, such as cosmetics, chemicals, oil & gas, electronics & semiconductors, automotive, aerospace, ceramics, plastics, rubber, and paints & coatings.
Life Science Equipment Market Assessment -by Geography